Alto Neuroscience, Inc.
Alto Neuroscience, Inc. (ANRO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ANRO · as of Jun 8, 2026
Key Statistics
Explore Alto Neuroscience, Inc. Data
anro stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 87.5%
The ANRO analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $34.60, representing +89.49% upside from the current price of $18.26.
Competitors & Peers
anro competitorsANRO
ACIU
ALDX
AMRN
CLLS
CTNMStock Performance
Full HistoryAbout Alto Neuroscience, Inc.
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company develops ALTO-100 for the treatment of patients wit…
what is alto neuroscience, inc. · anro stock overview · alto neuroscience, inc. company profile · who is alto neuroscience, inc. ceo · anro NYSE · alto neuroscience, inc. headquarters · alto neuroscience, inc. business segments
About Stock Overview & Key Data
Alto Neuroscience, Inc. (ANRO) is a Healthcare company in the Biotechnology industry, listed on NYSE since Feb 2, 2024. As of the latest trading session, ANRO stock price is $18.26, with a market capitalization of $640.8M. The stock has returned +618.90% over the past 12 months and +2.58% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Alto Neuroscience, Inc. stock is Buy, with an average 12-month price target of $34.60. In fiscal year 2025, Alto Neuroscience, Inc. reported revenue of — and net income of -$63.2M. For detailed data — including Alto Neuroscience, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Alto Neuroscience, Inc. (ANRO) stock price is $18.26. The stock is traded on NYSE under the ticker symbol ANRO. The 52-week range is $2.15 – $28.44.